Skip to main content
ALLURION TECHNOLOGIES, INC. logo

ALLURION TECHNOLOGIES, INC. — Investor Relations & Filings

Ticker · ALUR ISIN · US02008G1022 US Human health and social work activities
Open in API
Filings indexed 303 across all filing types
Latest filing 2024-10-29 Regulatory Filings
Country US United States of America
Listing US ALUR

About ALLURION TECHNOLOGIES, INC.

https://www.allurion.com/en

Allurion Technologies, Inc. is a company focused on ending obesity through its comprehensive weight-loss platform, the Allurion Program. The program's core component is a procedure-less, swallowable gastric balloon that is placed during an outpatient visit and passes naturally after approximately four months. This device is integrated into a full-stack solution that includes a digital ecosystem for real-time progress tracking via connected devices, an AI-powered coaching assistant, and personalized support from a multidisciplinary team of healthcare professionals. The platform is designed to promote sustainable, metabolically healthy weight loss by combining appetite regulation with behavioral change support. It can function as a standalone treatment or in combination with other therapies, including the company's AI-native compounded GLP-1 program.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed pursuant to the Securities Exchange Act of 1934. It includes information about the scheduling of the company's 2024 Annual Meeting of Stockholders, details about shareholder proposals and nominations, and proxy material timelines. The document is not a full annual report, earnings release, or financial statement, but rather a regulatory filing updating shareholders and the SEC about corporate governance and meeting logistics. It also references the filing of a proxy statement to come later. The document length is 7,210 characters, which is consistent with a detailed regulatory announcement rather than a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like MANG or PSI, since it does not announce management changes or provide proxy materials itself but rather announces meeting details and procedural information.
2024-10-29 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which includes information about the date and details of the company's upcoming 2024 Annual Meeting of Stockholders, including shareholder director nominations and proxy proposal deadlines. It is not a full annual report, earnings release, or financial statement, but rather a regulatory filing providing specific event information. The document also references the prospectus supplement and registration statement but primarily serves as a current report on a corporate event. Therefore, it fits best under Regulatory Filings (RNS) as a general SEC filing that does not fit other specific categories.
2024-10-29 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 26, 2024. It announces the date and details of the company's 2024 Annual Meeting of Stockholders, including the record date and instructions for shareholder proposals and nominations. The content focuses on shareholder director nominations and proxy material preparation, not on financial results, audit, or other report types. The document is relatively short (4646 characters) and serves as an announcement of meeting details and procedural information rather than a full report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-10-28 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically a Preliminary Proxy Statement for the 2024 Annual Meeting of Stockholders of Allurion Technologies, Inc. It includes detailed information about the meeting agenda, proposals to be voted on (such as director elections, stock split, share issuances, auditor ratification), voting instructions, and corporate governance matters. The document is not an announcement of a report, nor is it a financial report or earnings release. It is a solicitation document sent to shareholders to inform them and request their votes on various corporate matters at the upcoming annual meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just a brief announcement or notice.
2024-10-28 English
ALLURION TECHNOLOGIES INC.
Major Shareholding Notification
2024-10-24 English
Regulatory Filings 2024
Regulatory Filings
2024-10-08 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.